• Cancer Research and Biotechnology AG

    ZG
    active
    Check credit rating Timeline
    Check credit ratingCredit rating
    Register number: CH-170.3.041.093-2
    Sector: Research and development

    Age of the company

    7 years

    Turnover in CHF

    PremiumPremium

    Capital in CHF

    100'000

    Employees

    PremiumPremium

    Active brands

    0

    Reports for Cancer Research and Biotechnology AG

    preview

    Credit rating information

    Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company. Find out more
    preview

    Economic information

    Comprehensive information about the economic situation of a company. Find out more
    preview

    Payment behaviour

    Assessment of the payment behaviour based on past invoices. Find out more
    preview

    Payment collection information

    Overview of current and past debt enforcement proceedings. Find out more

    Company dossier as PDF

    Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.
    Retrieve company dossier

    About Cancer Research and Biotechnology AG

    • Cancer Research and Biotechnology AG has its legal headquarters in Baar and is active. It operates in the sector «Research and development».
    • The management of the company Cancer Research and Biotechnology AG consists of 2 persons.
    • Under «Notifications» you can see all modifications to the commercial register entry. The most recent modification was on 13.08.2021.
    • The reported UID is the following: CHE-428.033.043.
    • On the same address there are 74 other active companies registered. These include: AB-Perfekt Bau GmbH, AFT-Trading GmbH, Alelino HR & Payroll Consulting GmbH.

    Commercial register information

    Source: SOGC

    Sector

    Research and development

    Purpose (Original language) Customise the company purpose with just a few clicks.

    Forschung, Entwicklung und Vermarktung oder anderweitige Kommerzialisierung von Produkten und Applikationen in den Bereichen Pharmazie und Biotechnologie, sowie Erwerb, Verwaltung und Veräusserung von Beteiligungen, Patenten und Lizenzen; vollständige Zweckumschreibung gemäss Statuten.

    Auditor

    Source: SOGC

    Former auditor (1)
    Name City Since Until
    Sikura Revisionsgesellschaft AG
    Hünenberg 22.02.2017 18.03.2021

    Other company names

    Source: SOGC

    Past and translated company names

    • Cancer Research and Biotechnology Ltd
    • Cancer Research and Biotechnology SA
    • Protea Trading Ltd
    • Protea Trading SA
    • Protea Trading AG
    Would you like to update the company name? Click here.

    Ownership structure

    No information on the ownership structure is known to us.

    Holdings

    No information on holdings is known to us.

    Newest SOGC notifications: Cancer Research and Biotechnology AG

    The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications

    SOGC 210813/2021 - 13.08.2021
    Categories: Change in management

    Publication number: HR02-1005270496, Commercial Registry Office Zug, (170)

    Cancer Research and Biotechnology AG, in Baar, CHE-428.033.043, Aktiengesellschaft (SHAB Nr. 55 vom 19.03.2021, Publ. 1005128283).

    Ausgeschiedene Personen und erloschene Unterschriften:
    Stäger, Cyrill Alexander, von Glarus Süd, in Zug, Mitglied des Verwaltungsrates, mit Einzelunterschrift.

    Eingetragene Personen neu oder mutierend:
    Sarvanto, Kari, finnischer Staatsangehöriger, in Zug, Präsident des Verwaltungsrates, mit Einzelunterschrift;
    Karttunen, Kai Juhani, finnischer Staatsangehöriger, in Unterägeri, Mitglied des Verwaltungsrates, mit Einzelunterschrift.

    SOGC 210319/2021 - 19.03.2021
    Categories: Change of auditors

    Publication number: HR02-1005128283, Commercial Registry Office Zug, (170)

    Cancer Research and Biotechnology AG, in Baar, CHE-428.033.043, Aktiengesellschaft (SHAB Nr. 77 vom 23.04.2019, Publ. 1004614741). Mit Erklärung vom 05.03.2021 wurde auf die eingeschränkte Revision verzichtet.

    Ausgeschiedene Personen und erloschene Unterschriften:
    Sikura Revisionsgesellschaft AG (CHE-101.607.168), in Hünenberg, Revisionsstelle.

    SOGC 190423/2019 - 23.04.2019
    Categories: Change of company name, Change of company purpose

    Publication number: HR02-1004614741, Commercial Registry Office Zug, (170)

    Protea Trading AG, in Baar, CHE-428.033.043, Aktiengesellschaft (SHAB Nr. 52 vom 15.03.2019, Publ. 1004588589).

    Statutenänderung:
    05.04.2019.

    Firma neu:
    Cancer Research and Biotechnology AG.

    Uebersetzungen der Firma neu:
    (Cancer Research and Biotechnology SA) (Cancer Research and Biotechnology Ltd).

    Zweck neu:
    Forschung, Entwicklung und Vermarktung oder anderweitige Kommerzialisierung von Produkten und Applikationen in den Bereichen Pharmazie und Biotechnologie, sowie Erwerb, Verwaltung und Veräusserung von Beteiligungen, Patenten und Lizenzen;
    vollständige Zweckumschreibung gemäss Statuten.

    Hit list

    Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.

    Title
    Confirm